MFS New Discovery Fund Class C MNDCX

Morningstar Medalist Rating
  • NAV / 1-Day Return $18.71  /  +2.86 %
  • Fund Size $2.0B
  • Adjusted Expense Ratio 1.960%
  • Net Expense Ratio 2.020%
  • Fee Level: Distribution Average
  • Share Class Type Level Load
  • Morningstar Category Small Growth
  • Equity Style Box (Funds) Small Growth
  • Minimum Initial Investment $1,000
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 68%

Morningstar’s Analysis MNDCX

Will MNDCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still a strong small-growth vehicle for the long haul.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

MFS New Discovery’s strengths remain intact, and it retains its Above Average People and Process Pillar ratings.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MNDCX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 19.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Currency Cash CASH_USD

3.18 65M
Cash and Equivalents

Ligand Pharmaceuticals Inc

2.68 55M
Healthcare

CACI International Inc Class A

2.58 53M
Technology

Merit Medical Systems Inc

2.08 43M
Healthcare

Element Solutions Inc

1.79 37M
Basic Materials

Moog Inc Class A

1.76 36M
Industrials

The Chefs' Warehouse Inc

1.74 36M
Consumer Defensive

Charles River Laboratories International Inc

1.74 36M
Healthcare

Waystar Holding Corp

1.66 34M
Healthcare

Finning International Inc

1.63 33M
Industrials

Sponsor Center